Accuracy of chimeric proteins in the serological diagnosis of chronic chagas disease - a Phase II study.

Fred Luciano Neves SantosPaola Alejandra Fiorani CeledonNilson Ivo Tonin ZanchinWayner Vieira de SouzaEdimilson Domingos da SilvaLeonardo FotiMarco Aurélio KriegerYara de Miranda Gomes

Published in: PLoS neglected tropical diseases (2017)

Our findings indicate that the IBMP-8.4 antigen can be safely used in serological tests for T. cruzi screening in blood banks and for chronic CD laboratory diagnosis.

Keyphrases

phase ii study
open label
cell therapy
randomized controlled trial
stem cells
clinical trial
radiation therapy
drug induced
bone marrow